Similar articles

• Systemic chemotherapy and its implications for resection of colorectal liver metastasis.

  Robinson S, Manas DM, Pedley I, Mann D, White SA. Robinson S, et al. Surg Oncol. 2011 Jun;20(2):57-72. doi: 10.1016/j.suronc.2009.10.002. Epub 2009 Dec 3. Surg Oncol. 2011. PMID: 19962301 Review.
• Trials on preoperative chemotherapy in resectable colorectal liver metastases need prospective evaluation of predictive factors of response.

  Nasti G, Ottaiano A, Rosario Iaffaioli V, Berretta M, Delrio P. Nasti G, et al. J Clin Oncol. 2008 Aug 1;26(22):3812-3; author reply 3813. doi: 10.1200/JCO.2008.17.8301. J Clin Oncol. 2008. PMID: 18669474 No abstract available.
• [What are the roles of neoadjuvant, adjuvant and palliative chemotherapy in the management of hepatic metastasis of colorectal origin?].

  Guimbaud R; ANAES. Guimbaud R, et al. Gastroenterol Clin Biol. 2003 Mar;27 Spec No 2:B14-5, B63-79. Gastroenterol Clin Biol. 2003. PMID: 12637873 French. No abstract available.
• Control arm for surgery alone is needed but difficult to obtain in randomized trials for adjuvant chemotherapy after liver resection for colorectal metastases.

  Kokudo N, Hasegawa K, Makuuchi M. Kokudo N, et al. J Clin Oncol. 2007 Apr 1;25(10):1299-300; author reply 1300. doi: 10.1200/JCO.2006.09.9069. J Clin Oncol. 2007. PMID: 17401028 No abstract available.
• [Therapeutic strategies in colorectal cancer].

  Flieger D, Keller R, Fischbach W. Flieger D, et al. Dtsch Med Wochenschr. 2003 Sep 12;128(37):1902-7. doi: 10.1055/s-2003-42159. Dtsch Med Wochenschr. 2003. PMID: 12970825 Review. German. No abstract available.